News
Altria's dividend yield is 7%, even as it trades at 11 times estimated earnings over the next 12 months – a 40% premium to ...
Zacks Investment Research on MSN1d
Pfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold?Pfizer's PFE stock has risen 5% since it reported first-quarter results on April 29. While the company beat estimates for ...
A study published earlier this week in Nature Communications using claims data from the US Veterans Affairs (VA) Healthcare ...
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.” ...
Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...
Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after ...
Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...
Dr. Tedros Adhanom Ghebreyesus declares the end of the COVID-19 pandemic, highlighting global vaccination efforts and future ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback